Mounjaro® 10mg/0.5mL (Tirzepatide Injection) – Lilly

Description

Mounjaro (Tirzepatide Injection) for Enhanced Weight Loss

Step into a new chapter with Mounjaro 10mg/0.5mL, a cutting-edge tirzepatide injection designed to assist in weight management. Primarily developed for type 2 diabetes management, Mounjaro offers off-label potential to achieve ideal body composition.

The Details:

• Dosage: FOR RESEARCH PURPOSES ONLY. The typical recommended starting dosage for weight loss is 2.5 mg per week for 4 weeks. After the initial 4 weeks, the doctor may increase the dose by 2.5 mg every 4 weeks, depending on how the body responds to treatment and the amount of weight loss experienced.
• Quantity: 10mg/o.5mL
• Packaging: Sealed, tamper-proof vial
• Source: Mounjaro by Eli Lilly, Tirzepatide Injection

Key Features of Mounjaro 10mg/0.5mL

• Enhanced Weight Loss: Achieve your body goals with demonstrated efficacy in reducing body weight by up to 20% over 72 weeks.
• Improved Body Composition: Target stubborn abdominal fat for a leaner look.
• Increased Insulin Sensitivity: Boost glucose uptake for better workout performance and more intense training sessions.
• Nutrient Partitioning: Optimize muscle gain while minimizing fat storage.
• Enhanced Recovery: Support muscle recovery processes for improved endurance and faster recovery times.
• Appetite Control: Maintain a calorie deficit with effective appetite regulation.
• Synergy with Exercise: Enhance metabolic efficiency with regular exercise for superior fitness results.